Vol. 7, Issue 5 (2018)
Unani medicines used in the treatment of diabetes induced erectile dysfunction: A review
Waseem Ahmed HM, MA Siddiqui, MA Quamri and Anzar Alam
Erectile Dysfunction (ED) or Impotence is defined as inability to achieve or maintain an erection sufficient for satisfactory sexual performance. Diabetes mellitus (DM) is one of most prevalent degenerative Polygenic disease affecting app. 69.2 million peoples in India, emerging as a key health problem particularly in Urban areas. Erectile dysfunction is one of the important complications of DM in men affecting more than 50% of them. ED leads to depression, anxiety and can contribute to marital breakdowns where as men are reluctant to seek help for fear embarrassment and become isolated within their relationship. Diabetes induced erectile dysfunction (DIED) has various aetiological factors; hence the treatment is also multimodal. Despite the emphasis on organic ED, pure psychogenic ED occurs, evidence suggests that up to 80 percent of cases have an organic cause. Over exertion, physiological disturbances, lowered level of hormones and strained relationship with partner are the main causes for this disease. One of the etiological factors for diabetes and its complications is oxidative stress and hence an antidiabetic compound with anti-oxidant property would be beneficial. Presently Phosphodiesterase-5 inhibitors are the first line monotherapy for ED, such as Sildenafil and Tadalafil. However, they are not depicted from side effects. In Unani System of medicine, ED is well-defined under the heading of Zoaf-e-bah with the synonyms such as Nuqs-e-Nauoz, Zoaf-e-Inaaz, Isterqa-e-Qazeeb. An individual with such a problem might not immediately consult a physician, and try self-medication. Thus, in any case one finds herbal (Unani) remedies as an easy, economic and safe option. This article proposes few Unani Medicines which may be used for treatment of DIED.
How to cite this article:
Waseem Ahmed HM, MA Siddiqui, MA Quamri, Anzar Alam. Unani medicines used in the treatment of diabetes induced erectile dysfunction: A review. Pharma Innovation 2018;7(5):113-117.